Cibus, Inc. (NASDAQ:CBUS) Short Interest Up 8.0% in May

Cibus, Inc. (NASDAQ:CBUS) was the recipient of a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 659,100 shares, a growth of 8.0% from the May 15th total of 610,400 shares. Currently, 4.6% of the company’s shares are short sold. Based on an average trading volume of 90,900 shares, the short-interest ratio is presently 7.3 days.

Institutional Trading of Cibus

Large investors have recently added to or reduced their stakes in the company. FMR LLC lifted its holdings in shares of Cibus by 0.4% in the 3rd quarter. FMR LLC now owns 2,496,152 shares of the company’s stock valued at $45,480,000 after buying an additional 8,763 shares during the period. Vanguard Group Inc. lifted its holdings in shares of Cibus by 3.7% in the 1st quarter. Vanguard Group Inc. now owns 721,945 shares of the company’s stock valued at $16,215,000 after buying an additional 26,017 shares during the period. Indie Asset Partners LLC lifted its holdings in shares of Cibus by 30.1% in the 4th quarter. Indie Asset Partners LLC now owns 16,929 shares of the company’s stock valued at $332,000 after buying an additional 3,921 shares during the period. Blue Trust Inc. acquired a new position in shares of Cibus in the 4th quarter valued at about $301,000. Finally, FineMark National Bank & Trust acquired a new position in shares of Cibus in the 3rd quarter valued at about $300,000. Hedge funds and other institutional investors own 33.81% of the company’s stock.

Cibus Stock Up 0.6 %

CBUS stock traded up $0.06 on Tuesday, hitting $9.45. 232,441 shares of the company’s stock were exchanged, compared to its average volume of 76,573. Cibus has a 12-month low of $8.90 and a 12-month high of $24.61. The firm has a 50 day moving average price of $15.42 and a two-hundred day moving average price of $17.01.

Cibus (NASDAQ:CBUS) last announced its earnings results on Thursday, May 9th. The company reported ($1.12) earnings per share for the quarter, missing the consensus estimate of ($1.01) by ($0.11). Cibus had a negative return on equity of 23.33% and a negative net margin of 12,313.28%. The business had revenue of $0.55 million for the quarter, compared to analysts’ expectations of $0.40 million. During the same quarter last year, the firm earned ($5.45) earnings per share. On average, research analysts expect that Cibus will post -3.22 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reaffirmed a “buy” rating and set a $25.00 target price on shares of Cibus in a research report on Friday, May 10th.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.